Form 4: Nutex Health CEO Thomas Vo Reports Stock Transactions
SEC Form 4 Filing
CEO Thomas Vo reports acquisition and disposal of Nutex Health stock, including transactions related to restricted stock units and tax obligations.
Summary
- On March 1, 2025, Thomas Vo exercised restricted stock units, converting them into 5,000 shares of common stock.
- Also on March 1, 2025, Vo acquired 5,000 shares at $0.
- On April 4, 2025, 895 shares were sold at $72.0972 to cover tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, Vo directly and indirectly beneficially owns 1,837,879 shares of Nutex Health, Inc.
- Vo also directly owns 20,000 derivative securities in the form of Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the trading activities of key personnel.
Stakeholder Impact
- Shareholders are informed about the CEO's stock transactions, providing transparency into insider activity.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Restricted stock units converted into 5,000 shares of common stock. |
| 03/01/2025 | Acquisition of 5,000 shares of common stock. |
| 03/10/2025 | Grant date of RSUs vesting in three equal installments. |
| 03/01/2026 | First vesting date of RSUs. |
| 03/01/2027 | Second vesting date of RSUs. |
| 03/01/2028 | Third vesting date of RSUs. |
| 04/04/2025 | Sale of 895 shares to cover tax withholding obligations. |
| 04/14/2025 | Date of Form 4 signature. |
Keywords
Form 4, Nutex Health, Thomas Vo, Stock Transaction, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.